Development and Validation of a Clinical Score for Predicting Risk of Adenoma at Screening Colonoscopy
-
2015/06/01
-
Details
-
Personal Author:Allen JA ; Church, Timothy R. ; Feld AD ; Jordan PA ; Kauff ND ; Kim A ; Mills GM ; O'Brien MJ ; Shanley R ; Shaukat A ; Winawer SJ ; Zauber AG
-
Description:Background: Currently, no clinical tools use demographic and risk factor information to predict the risk of finding an adenoma in individuals undergoing colon cancer screening. Such a tool would be valuable for identifying those who would most benefit from screening colonoscopy. Methods: We used baseline data from men and women who underwent screening colonoscopy from the randomized, multicenter National Colonoscopy Study (NCS) to develop and validate an adenoma risk model. The study, conducted at three sites in the United States (Minneapolis, MN; Seattle, WA; and Shreveport, LA) asked all participants to complete baseline questionnaires on clinical risk factors and family history. Model parameters estimated from logistic regression yielded an area under the receiver operating characteristic curve (AUROCC) used to assess prediction. Results: Five hundred forty-one subjects were included in the development model, and 1,334 in the validation of the risk score. Variables in the prediction of adenoma risk for colonoscopy screening were age (likelihood ratio test for overall contribution to model, P < 0.001), male sex (P < 0.001), body mass index (P < 0.001), family history of at least one first-degree relative with colorectal cancer (P = 0.036), and smoking history (P < 0.001). The adjusted AUROCC of 0.67 [95% confidence interval (CI), 0.61-0.74] for the derivation cohort was not statistically significantly different from that in the validation cohort. The adjusted AUROCC for the entire cohort was 0.64 (95% CI, 0.60-0.67). Conclusion: We developed and validated a simple well-calibrated risk score. Impact: This tool may be useful for estimating risk of adenomas in screening eligible men and women. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1055-9965
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:24
-
Issue:6
-
NIOSHTIC Number:nn:20064577
-
Citation:Cancer Epidemiol Biomark Prev 2015 Jun; 24(6):913-920
-
Contact Point Address:Aasma Shaukat, University of Minnesota, 1 Veterans Drive, Minneapolis, MN 55417
-
Email:haukat@umn.edu
-
Federal Fiscal Year:2015
-
Performing Organization:University of Minnesota Twin Cities
-
Peer Reviewed:True
-
Start Date:20050701
-
Source Full Name:Cancer Epidemiology, Biomarkers & Prevention
-
End Date:20250630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:d025cb746d9791d1913bfc378d8a706621fc36891c6faa6ef1f883aa4b19ffcc98e9359eead792905aa0fa14b7c25caa77e9c52b40281d3d42af428440a3a05e
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like